Research programme: malaria vaccine - EpiVax
Latest Information Update: 15 Dec 2021
At a glance
- Originator EpiVax
- Class Antimalarials; Malaria vaccines; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Malaria